Form D · Other Health Care
CHRONO THERAPEUTICS INC.
Hayward, CA · CIK 0001601983
Offering snapshot reported Sep 9, 2016 · SEC filing
- Reported sold
- $37.6M Offering amount: $47.6M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2016 | Initial | $37,606,945 | No comparison | 22 | SEC filing |
| Jun 13, 2014 | Initial | $13,282,116 | No comparison | 31 | SEC filing |
| Mar 10, 2014 | Initial | $500,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-270385
Shares of Series B Preferred Stock and shares of Common Stock issuable upon conversion of the shares of Series B Preferred Stock.
Source: Form D, filed Sep 9, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guy Dipierro | Director |
| Wende Hutton | Director |
| Steven James | Director |
| Tim Kilgallon | Director |
| Aidan King | Director |
| Alan Levy | Director, Executive |
| Alan Levy, Ph.D. | Director, Executive |
| Anthony Rimac | Executive |
| Elizabeth Rockett | Director |
| James W. Young | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3953 Point Eden Way
Hayward, CA, 94545
Hayward, CA, 94545